Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Martin Babler currently holds 29,804 shares of Prelude Therapeutics Inc (PRLD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Martin Babler has been a net seller of PRLD stock. They have purchased $0 and sold $3.4M worth of shares.
Martin Babler's most recent insider trade was on Jun 23, 2026, when they sold 29,804 shares at $0.00 per share.
Martin Babler serves as Executive at Prelude Therapeutics Inc (PRLD). They have executed 53 insider transactions totaling $3.4M over their tenure at the company.
Martin Babler holds the position of Executive at Prelude Therapeutics Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Martin Babler has shown a selling trading pattern, with $0 in total purchases and $3.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Martin Babler was on Sep 28, 2020, when they sold $3.9M worth of PRNB shares. This transaction involved 39,179 shares at $100.00 per share.
Martin Babler currently owns 29,804 shares of Prelude Therapeutics Inc (PRLD), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Martin Babler's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Martin Babler has 53 Form 4 filings on record as an insider at Prelude Therapeutics Inc.
Set alerts for Martin Babler and 40,000+ other insiders.